Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines

Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines

BNT162b2 (BioNTech/Pfizer) was the first SARS-CoV-2 mRNA vaccine approved by the European Medicines Agency. We monitored the long-term humoral responses of healthcare workers (HCWs) who received three vaccine doses. A total of 59 healthcare workers were studied: 47 were never SARS-CoV-2-infected (na...

Full description

Bibliographic Details
Main Authors: Roberta Mancuso, Simone Agostini, Lorenzo Agostino Citterio, Debora Chiarini, Maria Antonia Santangelo, Mario Clerici
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Vaccines
Subjects:
SARS-CoV-2
antibodies
mRNA vaccines
rehabilitation
humoral response
BNT162b/Pfizer/Comirnaty
Online Access:https://www.mdpi.com/2076-393X/10/10/1649

Internet

https://www.mdpi.com/2076-393X/10/10/1649

Similar Items